Literature DB >> 3035736

Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

M Turner-Warwick, W McAllister, R Lawrence, A Britten, P L Haslam.   

Abstract

Thirty two patients with persisting pulmonary sarcoidosis fulfilling defined criteria for treatment were managed according to a standard clinical protocol. In this an attempt was made to achieve and maintain maximal radiographic and physiological improvement with individually titrated doses of corticosteroids. Lavage cell counts, serum angiotensin converting enzyme (SACE) determinations, and gallium-67 scans were planned at standard intervals but were not used in management decisions. The study analysed serial measurements in relation to changes in the clinical measurements. Twelve patients' radiographs showed complete clearing, seven cleared partially, and 13 had partial clearing with evidence of fibrosis. There was no predictive value in the initial lavage lymphocyte counts or the SACE or gallium measurements. Notably, in seven patients, substantial radiographic improvement was observed when the initial lavage lymphocyte counts were normal. Higher initial lavage neutrophil counts (p less than 0.02), higher initial radiographic profusion scores (p less than 0.02), and lower vital capacity (p less than 0.01) and carbon monoxide transfer factor (p less than 0.05) were related to incomplete clearing. A repeat study of the patients when their radiograph had cleared maximally showed that the levels of lavage lymphocytes, SACE, and gallium tended to fall, but frequently remained raised even in the presence of a normal radiograph or vital capacity or both. On the other hand, however, most of the patients with a normal lavage lymphocyte count showed persisting abnormality of the radiograph, lung function measurements, SACE, and gallium scan (or of at least one of these indices). The interrelationships between changes in clinical indices (radiograph, vital capacity, and transfer factor) and in lavage lymphocyte counts, SACE, and gallium scans showed that concordance was fairly poor in each comparison; lavage lymphocytes showed a greater major discordance than did the other pairs of measurements. Symptom free patients with normal or stable radiographic appearances have been followed for many months and have shown no clinical deterioration despite abnormal lavage lymphocyte counts, SACE, and gallium scans. Radiographic relapse, within the criteria defined, was seen in only four patients during the study; this was reflected in the gallium counts in three and in SACE and lavage lymphocyte counts measurements in two. It is concluded that serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans are not consistently more sensitive methods by which to monitor patients with sarcoidosis during treatment than are serial measurements of high quality radiographs and results of standard lung function tests.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3035736      PMCID: PMC460538          DOI: 10.1136/thx.41.12.903

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  A sensitive fluorimetric assay for serum angiotensin-converting enzyme.

Authors:  J Friedland; E Silverstein
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

2.  Accurate quantification of cells recovered by bronchoalveolar lavage.

Authors:  C Saltini; A J Hance; V J Ferrans; F Basset; P B Bitterman; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-10

3.  Lung biopsy in sarcoidosis.

Authors:  C H Koontz
Journal:  Chest       Date:  1978-08       Impact factor: 9.410

4.  67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis.

Authors:  C Alberts; J B van der Schoot; A S Groen
Journal:  Eur J Nucl Med       Date:  1981

5.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.

Authors:  P L Haslam; C W Turton; A Lukoszek; A J Salsbury; A Dewar; J V Collins; M Turner-Warwick
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

6.  Localization of the immune response in sarcoidosis.

Authors:  G W Hunninghake; J D Fulmer; R C Young; J E Gadek; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1979-07

7.  Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment.

Authors:  J L Ceuppens; L M Lacquet; G Mariën; M Demedts; A van den Eeckhout; E Stevens
Journal:  Am Rev Respir Dis       Date:  1984-04

8.  Ethylenediamine-induced asthma.

Authors:  S Lam; M Chan-Yeung
Journal:  Am Rev Respir Dis       Date:  1980-01

9.  Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy.

Authors:  G M Ainslie; S R Benatar
Journal:  Q J Med       Date:  1985-06
  9 in total
  12 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 2.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

3.  Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests.

Authors:  G Gafà; N Sverzellati; E Bonati; A Chetta; F Franco; E Rabaiotti; M De Filippo; E Marangio; D Figoli; T Meschi; M Zompatori; C Rossi
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

4.  Glucocorticosteroids and pulmonary sarcoidosis.

Authors:  O Selroos
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 5.  The K veim response: still useful, still a puzzle.

Authors:  C S Munro; D N Mitchell
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

6.  Bronchoalveolar lavage cell counts as a predictor of short term outcome in pulmonary sarcoidosis.

Authors:  N M Foley; A P Coral; K Tung; B N Hudspith; D G James; N M Johnson
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

7.  Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.

Authors:  G M Ainslie; L W Poulter; R M du Bois
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

8.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

9.  Predictive value of bronchoalveolar lavage cell analysis in sarcoidosis.

Authors:  L Bjermer; L Rosenhall; T Angström; R Hällgren
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

10.  The Heerfordt-Waldenström syndrome as an initial presentation of sarcoidosis.

Authors:  M Carter Denny; A Domnica Fotino
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.